• FDA Requests More Restrictions on Ovarian Cancer Drugs

    12 days ago - By Medscape

    The limits on second-line prescribing for one of the drugs, rucaparib, could put the company's financial future at risk, a company report shows.
    Medscape Medical News
    Read more ...